Calcineurin Inhibitors: all 995 studies that test it
Page 8 of 10. Open to participants first (83), then studies with results posted, then the rest; newest registration first within each.
- Low-Dose Conditioning Followed by Donor Stem Cell Transplant in Treating Patients With Severe Systemic SclerosisWithdrawnNCT01047072Phase 2
- Comparison of Tacrolimus and Myfortic Versus Tacrolimus and SirolimusWithdrawnNCT01038505Phase 4
- A Study to Examine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy AdultsCompletedNCT01038167Phase 1
- Oral Ciclosporin for Colonic Release in Ulcerative Colitis (CyCol™)CompletedNCT01033305Phase 2
- Efficacy of Topical Cyclosporine A for Treatment and Prevention of Graft Rejection in Corneal Grafts With Previous Rejection EpisodesCompletedNCT01028443Phase 4
- Donor Stem Cell Transplant or Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia in RemissionCompletedNCT01020734Phase 2
- A Study to Compare Safety and Efficacy of Prograf + Myfortic and Advagraf + Myfortic in Liver Transplantation PatientsCompletedNCT01018914Phase 4
- Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell TransplantationCompletedNCT00993343Phase 3
- Trial of Cyclosporine for Myocardial Protection During Open Heart SurgeryTerminatedNCT00990795Phase 1
- Pharmacological Postconditioning During the Aortic Valvular SurgeryCompletedNCT00987207Phase 3
- Pharmacokinetic Study to Rectal and Sublingual Administration of Tacrolimus in Future Kidney Transplant PatientsStatus unknownNCT00987103Phase 1
- Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune StudyCompletedNCT00976300Phase 2
- Bayesian Dose Adjustment of Immunosuppressants After Lung TransplantationTerminatedNCT00975663Phase 4
- Therapeutic Effect of Low-dose Prednisone Combined With MMF and FK506 in Focal Segmental GlomerulosclerosisStatus unknownNCT00956059Not applicable
- Enhancement of Functional Recovery After Peripheral Nerve Injury With TacrolimusWithdrawnNCT00950391Phase 1/2
- Cyclosporine Dose Adjustment According to Calcineurin Activity After Allogeneic Hematopoietic Stem-cell TransplantationCompletedNCT00948727Phase 2
- Initial Dosage Range of Tacrolimus by Genotyping in Chinese Renal TransplantationCompletedNCT00935298Phase 4
- Twice Daily Versus Once Daily Administration of the Tacrolimus in Lung TransplantationTerminatedNCT00930241Phase 3
- Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under OcclusionCompletedNCT00925730Phase 4
- Ciclosporin in the Management of New Type 1 Reactions in LeprosyCompletedNCT00919815Phase 2/3
- Ciclosporin in the Management of Chronic or Recurrent Erythema Nodosum LeprosumCompletedNCT00919776Phase 2
- Ciclosporin in the Management of New Erythema Nodosum LeprosumCompletedNCT00919542Phase 2
- Ciclosporin in the Management of Steroid Resistant Type 1 Reactions in LeprosyCompletedNCT00919451Phase 2
- Minimizing Immunosuppression in Old for Old Kidney TransplantationCompletedNCT00912678Phase 4
- Pharmacokinetics of Tacrolimus in Liver Transplantation Patients Treated With Prograf and Modified Release TacrolimusCompletedNCT00909571Phase 3
- Low Dose Cyclosporin and Methotrexate Therapy in DiabetesCompletedNCT00905073Not applicable
- Calcineurin Inhibitor (CNI) Versus Steroid Cessation in Renal TransplantationStatus unknownNCT00903188Phase 4
- Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow FailureStatus unknownNCT00895739Phase 2
- Efficacy and Safety of Human Lipoprotein Lipase (LPL)[S447X] Expressed by an Adeno-Associated Viral Vector in LPL-deficient SubjectsCompletedNCT00891306Phase 2/3
- Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies.CompletedNCT00890500Phase 1
- Benefit of Early Protocol Biopsy and Treatment of Subclinical RejectionCompletedNCT00885820Phase 4
- Tandem Stem Cell Transplantation for Non-Hodgkin's LymphomaActive, not recruitingNCT00882895Phase 2
- Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)TerminatedNCT00881556Early Phase 1
- Assess the Efficacy and Safety of Multi-target Therapy in Lupus NephritisCompletedNCT00876616Not applicable
- An Open Study Assessing Bioavailability of a Modified Formulation of Tacrolimus in Kidney Transplant RecipientsCompletedNCT00865137Phase 3
- Bioequivalence of Two Tacrolimus 0.1% Topical Ointment Formulations in Patients With Atopic DermatitisCompletedNCT00833079Phase 1
- Topical Cyclosporine vs. Placebo for Epiphora Associated With DocetaxelWithdrawnNCT00824811Phase 2
- Comparison of Extended Release Tacrolimus (Advagraf) and Cyclosporine A Microemulsion on Renal Function in Healthy VolunteersCompletedNCT00818194Phase 1
- Pharmacokinetics of Immunosuppressive Drugs in Heart Transplant PatientsCompletedNCT00812786Phase 4
- Vitiligo Treated With TL01 Combined With Tacrolimus Ointment Versus PlaceboCompletedNCT00807690Phase 3
- Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic DermatitisCompletedNCT00801957Phase 2
- Aerosol Cyclosporine in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00783107Phase 1
- Randomized Trial of Cyclosporine and Tacrolimus Therapy With Steroid Withdrawal in Living-Donor Renal TransplantationCompletedNCT00777933Not applicable
- Diabetogenicity of Cyclosporine and TacrolimusCompletedNCT00766909Phase 4
- Tacrolimus Versus Clobetasol Propionate in the Treatment of Vulvar Lichen SclerosusCompletedNCT00757874Phase 2
- Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung TransplantationCompletedNCT00755781Phase 3
- Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal TransplantationCompletedNCT00724022Phase 4
- A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients.CompletedNCT00720408Phase 3
- A Study to Assess the Safety and Efficacy of Prograf and MR4 in Kidney Transplantation PatientsCompletedNCT00720265Phase 3
- A Study to Assess the Safety and Efficacy of Prograf and MR4 in Liver Transplant RecipientsCompletedNCT00719745Phase 3
- A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant RecipientsCompletedNCT00717678Phase 3
- A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney RejectionCompletedNCT00717470Phase 4
- Study of Tacrolimus Immunosuppressive Therapy After Kidney TransplantationCompletedNCT00717379Phase 4
- Treatment of Severe Osteogenesis Imperfecta by Allogeneic Bone Marrow TransplantationCompletedNCT00705120Phase 1
- A Study To Compare Sirolimus Versus Tacrolimus In De Novo Simultaneous Pancreas- Kidney Allograft Recipients Receiving An Induction Therapy With Antithymocyte Globulin Plus Mycophenolate Mofetil Plus CorticosteroidsStatus unknownNCT00693446Phase 4
- Mycophenolate Mofetil (MMF) Discontinuation From a Tacrolimus/MMF/Steroid Triple Regimen After Kidney TransplantationCompletedNCT00693381Phase 3
- Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic DermatitisCompletedNCT00691262Phase 3
- Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic DermatitisCompletedNCT00691145Phase 3
- Protopic Ointment in Adult Atopic Eczema of the FaceCompletedNCT00690105Phase 4
- Protopic Ointment in Children Atopic EczemaCompletedNCT00689832Phase 4
- Total Marrow Irradiation for Refractory Acute LeukemiaCompletedNCT00686556Phase 1
- Tacrolimus/Sirolimus Versus Tacrolimus/Mycophenolate Mofetil (MMF) Versus Neoral/Sirolimus in Adult, Primary Kidney TransplantationCompletedNCT00681213Phase 4
- A Study Using Tacrolimus, Sirolimus and Bortezomib as Acute Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Peripheral Blood Stem Cell (PBSC) TransplantationCompletedNCT00670423Phase 1
- Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic DermatitisCompletedNCT00667160Phase 4
- Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact DermatitisCompletedNCT00667056Phase 4
- A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic DermatitisCompletedNCT00666302Phase 4
- Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic DermatitisCompletedNCT00666159Phase 4
- Comparison of Skin Thickness Under Treatment With Pimecrolimus 1% Cream, Hydrocortisonacetat 1% Cream, Betamethasonvalerat 0,1% Cream and Clobetasol-17-propionat 0,05% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHZ UltrasoundCompletedNCT00655512Phase 1
- A Study to Compare Early Steroid Withdrawal and Long-Term Steroid Maintenance Therapy in Kidney Transplant PatientsCompletedNCT00650468Phase 4
- Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis PatientsCompletedNCT00643071Phase 3
- Tacrolimus as Secondary Intervention vs. Continuation of Cyclosporine in Renal Transplant Patients With Chronic Renal Allograft Failure (CRAF)CompletedNCT00637143Phase 4
- Nonmyeloablative Allo SCT for the Treatment of Hematologic DisordersCompletedNCT00636909Phase 2
- Pharmacokinetic Drug Interaction Between Ezetimibe and Tacrolimus After Single Dose Administration in Healthy SubjectsCompletedNCT00621699Phase 1
- A Study to Evaluate and Compare the Efficacy and Safety of FK506MR vs Prograf® in Stable Liver Transplantation PatientsCompletedNCT00619398Phase 3
- Prospective, Multicenter Study of the Efficacy and Tolerance of Tacrolimus on Refractory Nephrotic Syndrome (RNS)CompletedNCT00615667Phase 3
- Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus NephritisCompletedNCT00615173Phase 3
- Sirolimus, Tacrolimus and Short Course Methotrexate for Prevention of Acute GVHD in Recipients of Mismatched Unrelated Donor Allogeneic Stem Cell TransplantationCompletedNCT00612274Early Phase 1
- Comparison of Atrophogenic Effect of Hydrocortison 1% Cream and Pimecrolimus 1% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHz Ultrasound of Uninvolved Skin in Patients With Atopic DermatitisCompletedNCT00610142Phase 2
- Tacrolimus During the Implantation and the Effect on Ischemia-reperfusion Injury in Liver TransplantationCompletedNCT00609388Phase 4
- Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus ErythematosusCompletedNCT00608673Not applicable
- Efficacy and Tolerability Study of Topical Ciclosporin in a Psoriasis Plaque TestCompletedNCT00578370Phase 1/2
- A Pilot Study for the Efficacy and Safety of Tacrolimus in the Treatment of Refractory Lupus NephritisStatus unknownNCT00569101Phase 2
- A Clinical Study in Children and Adolescents With Mild to Moderate Atopic DermatitisCompletedNCT00568412Phase 4
- Topical Cyclosporine and Disease ProgressionCompletedNCT00567983Phase 4
- Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal KeratoconjunctivitisCompletedNCT00567918Phase 3
- Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal KeratoconjunctivitisCompletedNCT00567762Phase 3
- Long-term Safety of Protopic in Atopic EczemaCompletedNCT00560378Phase 3
- Tacrolimus Ointment Long Term Safety in Young Children With Atopic DermatitisCompletedNCT00560326Phase 2
- TACrolimus in Renal Transplantation: Individualization by PharmacogeneticCompletedNCT00552201Phase 4
- Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)CompletedNCT00549289Phase 3
- Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)CompletedNCT00548301Phase 3
- Efficacy of Tacrolimus and I.V.-Immunoglobulins in Rasmussen EncephalitisStatus unknownNCT00545493Phase 2/3
- Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft FunctionStatus unknownNCT00541814Phase 4
- Benefit of Immunoprophylaxis on Fibrosis to Reduce Viral Load After Liver TransplantationCompletedNCT00538265Phase 4
- Tacrolimus Ointment Pharmacokinetics in Infants With Atopic DermatitisCompletedNCT00535691Phase 2
- Distribution of Tacrolimus in Skin, Atopic DermatitisCompletedNCT00534508Phase 2
- Interaction Between Rimonabant and Cyclosporine and TacrolimusCompletedNCT00525681Phase 4
- Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult PatientsCompletedNCT00523952Phase 3
- Study Comparing Standard Dose and Reduced Dose Tacrolimus With Sirolimus in Renal Transplant PatientsCompletedNCT00519116Phase 4
- Study Comparing Graft Function in Renal Allograft Recepients Receiving Reduced or Standard Dose CsA With SirolimusCompletedNCT00518375Phase 4